Neuronetics Inc
STIM2.520USD
-0.220-8.03%
收盤 11/06, 16:00（美東）報價延遲15分鐘
172.48M總市值
虧損本益比TTM
關於 Neuronetics Inc 公司
Neuronetics, Inc. 是一家專注於爲患有神經健康障礙的患者設計、開發和營銷產品的醫療技術公司。其 NeuroStar 精神健康高級療法是一種針對患有神經健康疾病的人的非藥物、非侵入性治療方法。除了向客戶銷售 NeuroStar 系統和相關治療課程外，該公司還在美國各地經營治療中心，提供 NeuroStar 高級療法（經顱磁刺激或 TMS）和 Spravato（艾氯胺酮鼻噴霧劑），用於治療重度抑鬱症 (MDD) 和其他精神健康障礙。NeuroStar 高級療法是針對成人 MDD 的 TMS 療法。Spravato 用於治療患有難治性抑鬱症的成年人和有自殺想法或行爲的 MDD 成年人的抑鬱症狀。該公司爲超過 51,000 名抑鬱症患者提供了超過 168 萬次治療。
Neuronetics Inc簡介
公司代碼STIM
公司名稱Neuronetics Inc
上市日期Jun 28, 2018
CEOMr. Keith J. Sullivan
員工數量716
證券類型Ordinary Share
年結日Jun 28
公司地址3222 Phoenixville Pike
城市MALVERN
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編19355
電話18776007555
網址https://neurostar.com/neuronetics/
公司代碼STIM
上市日期Jun 28, 2018
CEOMr. Keith J. Sullivan
Neuronetics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.03M
+0.32%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
588.77K
+1.82%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
335.45K
+2.30%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
185.35K
+4.12%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+27.05%
Mr. W. Andrew Macan
Mr. W. Andrew Macan
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
--
--
Dr. Avinash N. Amin, M.D.
Dr. Avinash N. Amin, M.D.
Director
Director
--
--
Mr. Mark Klausner
Mr. Mark Klausner
Managing Partner
Managing Partner
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.03M
+0.32%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
588.77K
+1.82%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
335.45K
+2.30%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
185.35K
+4.12%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+27.05%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Clinic revenue
23.02M
60.42%
Treatment sessions
11.05M
29.00%
NeuroStar Advanced Therapy System
3.65M
9.57%
Other
385.00K
1.01%
地區USD
名稱
營收
佔比
United States
37.66M
98.81%
International
452.00K
1.19%
業務
地區
業務USD
名稱
營收
佔比
Clinic revenue
23.02M
60.42%
Treatment sessions
11.05M
29.00%
NeuroStar Advanced Therapy System
3.65M
9.57%
Other
385.00K
1.01%
股東統計
更新時間: 8月23日 週六
更新時間: 8月23日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Madryn Asset Management, LP
30.28%
The Vanguard Group, Inc.
4.00%
BlackRock Institutional Trust Company, N.A.
2.99%
Cucuz (Sasha)
2.97%
Sullivan (Keith J)
2.35%
其他
57.41%
持股股東
持股股東
佔比
Madryn Asset Management, LP
30.28%
The Vanguard Group, Inc.
4.00%
BlackRock Institutional Trust Company, N.A.
2.99%
Cucuz (Sasha)
2.97%
Sullivan (Keith J)
2.35%
其他
57.41%
股東類型
持股股東
佔比
Private Equity
31.36%
Hedge Fund
10.96%
Investment Advisor
9.91%
Individual Investor
9.48%
Investment Advisor/Hedge Fund
4.83%
Research Firm
1.83%
Bank and Trust
0.10%
Pension Fund
0.07%
其他
31.47%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
196
39.02M
59.02%
-13.74M
2025Q2
187
47.56M
71.93%
-4.03M
2025Q1
191
47.19M
71.70%
-4.84M
2024Q4
155
36.70M
70.38%
+11.74M
2024Q3
153
14.58M
47.42%
-9.85M
2024Q2
159
20.22M
66.61%
-5.87M
2024Q1
183
20.38M
68.24%
-3.49M
2023Q4
191
18.37M
63.28%
-7.87M
2023Q3
201
19.69M
68.24%
-8.69M
2023Q2
222
21.10M
73.37%
-11.20M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Madryn Asset Management, LP
20.74M
31.36%
-3.50M
-14.44%
Aug 08, 2025
The Vanguard Group, Inc.
2.74M
4.15%
+436.54K
+18.93%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.05M
3.1%
+1.67M
+440.36%
Jun 30, 2025
Cucuz (Sasha)
2.02M
3.06%
+30.00K
+1.50%
May 22, 2025
Sullivan (Keith J)
1.61M
2.43%
--
--
Mar 24, 2025
Balyasny Asset Management LP
1.51M
2.28%
+92.05K
+6.50%
Jun 30, 2025
Ikarian Capital LLC
1.10M
1.66%
-300.00
-0.03%
Jun 30, 2025
Masters Capital Management, L.L.C.
1.00M
1.51%
--
--
Jun 30, 2025
Manatuck Hill Partners, LLC
920.00K
1.39%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
879.04K
1.33%
+556.27K
+172.34%
Jun 30, 2025
查看更多
持股ETF
更新時間: 21 小時前
更新時間: 21 小時前
機構名稱
佔比
AdvisorShares Psychedelics ETF
3.78%
Invesco NASDAQ Future Gen 200 ETF
0.4%
iShares Neuroscience and Healthcare ETF
0.2%
Vanguard US Momentum Factor ETF
0.06%
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
AdvisorShares Psychedelics ETF
佔比3.78%
Invesco NASDAQ Future Gen 200 ETF
佔比0.4%
iShares Neuroscience and Healthcare ETF
佔比0.2%
Vanguard US Momentum Factor ETF
佔比0.06%
iShares Micro-Cap ETF
佔比0.02%
iShares Russell 2000 Growth ETF
佔比0.01%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.01%
Avantis US Small Cap Equity ETF
佔比0%
ProShares Hedge Replication ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
